Login / Signup

Prognostic value of the Memorial Sloan Kettering Prognostic Score in metastatic pancreatic adenocarcinoma.

Justin M LebenthalJunting ZhengPaul A GlareEileen M O'ReillyAndrew C YangAndrew S Epstein
Published in: Cancer (2021)
The Memorial Sloan Kettering Prognostic Score (MPS) is a new scoring system that incorporates markers of inflammation found in individuals' blood at the diagnosis of metastatic pancreatic cancer. Data suggest that the MPS may help to determine prognosis.
Keyphrases
  • squamous cell carcinoma
  • small cell lung cancer
  • oxidative stress
  • electronic health record
  • big data
  • machine learning
  • deep learning